相似文献
1
Renal Biomarkers and Novel Therapies in Pediatric Nephrology: From Chronic Kidney Disease to Renal Transplantation.
J Clin Med. 2023 Jun 1;12(11):3810. doi: 10.3390/jcm12113810.
2
Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan.
Clin Exp Nephrol. 2016 Dec;20(6):918-925. doi: 10.1007/s10157-016-1231-6. Epub 2016 Jan 19.
3
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.
4
[Advanced chronic kidney disease].
Nefrologia. 2008;28 Suppl 3:3-6.
5
Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.
Pediatr Transplant. 2016 May;20(3):378-87. doi: 10.1111/petr.12682. Epub 2016 Feb 15.
6
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
7
CKD: The burden of disease invisible to research funders.
Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):65-84. doi: 10.1016/j.nefroe.2021.09.005.
8
Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities.
Acta Med Indones. 2023 Jan;55(1):1-3.
9
Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care.
PLoS One. 2015 May 20;10(5):e0127071. doi: 10.1371/journal.pone.0127071. eCollection 2015.
10
The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
Am J Kidney Dis. 2016 Sep;68(3):402-13. doi: 10.1053/j.ajkd.2016.03.414. Epub 2016 Apr 22.
本文引用的文献
1
Long-term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study.
Am J Med Genet A. 2023 Jul;191(7):1858-1869. doi: 10.1002/ajmg.a.63216. Epub 2023 Apr 20.
2
New perspectives in pediatric dialysis technologies: the case for neonates and infants with acute kidney injury.
Pediatr Nephrol. 2024 Jan;39(1):115-123. doi: 10.1007/s00467-023-05933-x. Epub 2023 Apr 4.
3
The outcome of acute kidney injury substages based on urinary cystatin C in critically ill children.
Ann Intensive Care. 2023 Mar 28;13(1):23. doi: 10.1186/s13613-023-01119-8.
4
Epidemiology data on the cost and outcomes associated with pediatric acute kidney injury.
Pediatr Res. 2023 Oct;94(4):1385-1391. doi: 10.1038/s41390-023-02564-8. Epub 2023 Mar 22.
5
Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.
Pediatr Nephrol. 2023 Aug;38(8):2643-2648. doi: 10.1007/s00467-023-05917-x. Epub 2023 Mar 14.
6
Clinical evaluation, accurate diagnosis and treatment of four pedigrees with Fabry's disease.
Front Pediatr. 2023 Feb 15;11:1057014. doi: 10.3389/fped.2023.1057014. eCollection 2023.
7
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1.
8
Incidence, predictors, and short-term outcomes of acute kidney injury in children with diabetic ketoacidosis: a systematic review.
Pediatr Nephrol. 2023 Jul;38(7):2023-2031. doi: 10.1007/s00467-023-05878-1. Epub 2023 Jan 27.
9
'Children Kidney Care Centers': Rationale, requirements and recommendations for best facilities and better future.
World J Nephrol. 2023 Jan 25;12(1):10-20. doi: 10.5527/wjn.v12.i1.10.
10
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1.
Children (Basel). 2022 Dec 26;10(1):47. doi: 10.3390/children10010047.
Zotero 插件